MedTrace Logo

Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange

NCT05534425 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2025-09-04

No results posted yet for this study

Summary

This randomized controlled trial will test whether a recently developed community-based intergenerational mentoring program known as Generation Xchange (GenX) can enhance antiviral resistance in older African-American women and men in a low-SES urban community. Additional studies will identify the biological processes that promote resistance to respiratory virus infections and viral disease in older African-American women and men.

Conditions

  • Virus Infection, RNA

Interventions

BEHAVIORAL

GenX intergenerational mentoring program

GenX trains older adults to collaborate with K-3rd grade teachers in mentoring high-need elementary school students in core reading and math skills.

Sponsors & Collaborators

Principal Investigators

  • Steven Cole, Ph.D. · Professor of Medicine & Psychiatry

  • Teresa E Seeman, Ph.D. · Professor of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-26
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05534425 on ClinicalTrials.gov